6527.TWO · CRYSTALVUE
Taiwan · RS rating 65 · As of 2026-10-08
| Price | 74.00 TWD |
|---|---|
| 1-day change | -1.3% |
| RS rating (overall / 1M / 3M / 12M) | 65 / 47 / 78 / 37 |
| Stage | Topping |
| Composite / Minervini / CANSLIM score | 39 / 22 / 40 |
| Industry group (rank) | Medical-Biomed/Biotech (53) |
| EPS growth Q/Q | +24.4% |
| Sales growth Q/Q | +15.7% |
| Distance from 52-week high | +15.2% |
| Market cap (USD) | $59.4M |